Latest Security News

Evolution Energy Minerals has secured full underwriting for its $1.45 million renounceable entitlement offer, ensuring the capital raise is fully backed ahead of the September 5 deadline.

Intelligent Monitoring Group has completed its $4.5 million acquisition of Western Advance, bolstering its presence in Western Australia's oil and gas security sector.

8common’s subsidiary Expense8 has renewed its contract with the NSW Department of Education for another two years, reinforcing its role as a key provider of travel and expense management software in government.

OM Holdings reported steady revenue of US$309.3 million in 1H 2025 despite a sharp EBITDA decline and net loss, while maintaining a strong cash position and advancing sustainability goals.

Cambium Bio has struck a licensing deal with Keke Medtech to commercialise its fibrin biologic in dental applications, unlocking new markets and non-dilutive funding.

NRW Holdings has agreed to acquire Fredon Industries for up to $200 million, introducing a new strategic pillar and broadening its service capabilities in energy transition and infrastructure. The deal is expected to complete by September 30, 2025, with strong earnings visibility for FY26.

Advanced Braking Technology (ABT) reported robust FY25 financial results marked by revenue growth and improved profitability, while advancing its strategic roadmap focused on mining safety innovations and global market expansion.

Emperor Energy has initiated a farm-in process to fund the Judith-2 appraisal well, aiming to unlock substantial gas reserves offshore Victoria and address tightening East Coast gas supply.

archTIS Limited has opened the retail component of a $17 million entitlement offer to support its acquisition of Spirion LLC’s assets, aiming to expand its US footprint and enhance its cybersecurity product suite.

PolyNovo Limited stands to benefit from proposed U.S. Medicare changes that introduce a flat reimbursement rate for outpatient wound care skin substitutes, potentially reshaping the competitive landscape in favour of cost-effective, clinically proven products.

Scalare Partners has successfully closed a $3.09 million capital raise, combining a $3 million placement and a Share Purchase Plan, to fund its acquisition of Tank Stream Labs and expand its technology portfolio.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.